Bisoprolol improves echocardiographic parameters of left ventricular diastolic function in patients with systemic hypertension

被引:5
作者
Ilgenli, T. Fikret
Kilicaslan, Fethi
Kirilmaz, Ata
Uzun, Mehmet
机构
[1] Golcuk Army Hosp, Dept Cardiol, Kocaeli, Turkey
[2] Gulhane Haydarpasa Teaching Hosp, Dept Cardiol, Istanbul, Turkey
[3] Gulhane Mil Med Acad, Dept Cardiol, Ankara, Turkey
关键词
bisoprolol; diastolic function; hypertension; echocardiography;
D O I
10.1159/000092766
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Left ventricular (LV) diastolic dysfunction (LVD) is a common complication secondary to hypertension. It has been reported that bisoprolol is effective in reducing blood pressure and has beneficial cardiac effects in patients with hypertension. However, its effect on LV diastolic function has not been studied in detail. In this study, we sought to determine bisoprolol's effect on left ventricle diastolic function. Data from 25 patients were statistically analyzed. Peaks E and A wave, E/A ratio, isovolumetric relaxation time and E wave deceleration time were measured echocardiographically. Doppler echocardiography measurements after bisoprolol treatment revealed an improvement in LV diastolic function. In conclusion, our results show that treatment with bisoprolol, improves echocardiographic parameters of LV diastolic function after 3 months of treatment. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 34 条
[1]   Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study [J].
Arnold, RH ;
Kotlyar, E ;
Hayward, C ;
Keogh, AM ;
Macdonald, PS .
HEART, 2003, 89 (03) :293-298
[2]  
BALDERISI M, 2005, CARDIOVASC ULTRASOUN, V5, P9
[3]   ANTIFIBROTIC EFFECTS OF SPIRONOLACTONE IN PREVENTING MYOCARDIAL FIBROSIS IN SYSTEMIC ARTERIAL-HYPERTENSION [J].
BRILLA, CG ;
MATSUBARA, LS ;
WEBER, KT .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (03) :A12-A16
[4]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[5]  
Demiralp Ergun, 2004, Anadolu Kardiyol Derg, V4, P323
[6]   EFFECTS OF BISOPROLOL ON LEFT-VENTRICULAR HYPERTROPHY IN ESSENTIAL-HYPERTENSION [J].
DETERESA, E ;
GONZALEZ, M ;
CAMACHOVAZQUEZ, C ;
TABUENCA, MJ .
CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (06) :837-843
[7]   Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: Analysis with magnetic resonance myocardial tagging [J].
Dubach, P ;
Myers, J ;
Bonetti, P ;
Schertler, T ;
Froelicher, V ;
Wagner, D ;
Scheidegger, M ;
Stuber, M ;
Luchinger, R ;
Schwitter, J ;
Hess, O .
AMERICAN HEART JOURNAL, 2002, 143 (04) :676-683
[8]   β-blocker improvement in diastolic performance:: The yin and yang of ventricular function changes [J].
Eichhorn, EJ ;
Grayburn, PA .
AMERICAN HEART JOURNAL, 2000, 139 (04) :584-586
[9]   LEFT-VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION - RELATION TO LEFT-VENTRICULAR MASS AND SYSTOLIC FUNCTION [J].
FOUAD, FM ;
SLOMINSKI, JM ;
TARAZI, RC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (06) :1500-1506
[10]   Prognosis in diastolic heart failure [J].
Franklin, KM ;
Aurigemma, GP .
PROGRESS IN CARDIOVASCULAR DISEASES, 2005, 47 (05) :333-339